IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates

Abstract : Targeting the expansion of pathogenic memory immune cells is a promising therapeutic strategy to prevent chronic autoimmune attacks. Here we investigate the therapeutic efficacy and mechanism of new anti-human IL-7Rα monoclonal antibodies (mAb) in non-human primates and show that, depending on the target epitope, a single injection of antagonistic anti-IL-7Rα mAbs induces a long-term control of skin inflammation despite repeated antigen challenges in presensitized monkeys. No modification in T cell numbers, phenotype, function or metabolism is observed in the peripheral blood or in response to polyclonal stimulation ex vivo. However, long-term in vivo hyporesponsiveness is associated with a significant decrease in the frequency of antigen-specific T cells producing IFN-γ upon antigen resti-mulation ex vivo. These findings indicate that chronic antigen-specific memory T cell responses can be controlled by anti-IL-7Rα mAbs, promoting and maintaining remission in T-cell mediated chronic inflammatory diseases.
Document type :
Journal articles
Complete list of metadatas

Cited literature [69 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02023397
Contributor : Ana Paula Dutra Azevedo <>
Submitted on : Monday, February 18, 2019 - 3:09:33 PM
Last modification on : Tuesday, June 25, 2019 - 3:36:37 PM
Long-term archiving on: Sunday, May 19, 2019 - 3:44:16 PM

File

Belarif NatCom 2018.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Lyssia Belarif, Caroline Mary, Lola Jacquemont, Hoa Mai, Richard Danger, et al.. IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates. Nature Communications, Nature Publishing Group, 2018, 9 (1), ⟨10.1038/s41467-018-06804-y⟩. ⟨inserm-02023397⟩

Share

Metrics

Record views

86

Files downloads

131